What is Withings?
Established in 2008 and headquartered in Issy-les-Moulineaux, France, Withings has evolved into a global leader in the design and distribution of smart health devices. The company specializes in bridging the gap between consumer electronics and medical-grade health monitoring, offering a comprehensive ecosystem that includes smart scales, blood pressure monitors, and advanced wearable trackers. By integrating sophisticated data analytics with user-centric hardware, Withings provides both individual consumers and healthcare professionals with actionable insights into long-term wellness and chronic disease management. Its market position is defined by a commitment to clinical accuracy and seamless digital integration, making it a cornerstone of the modern digital health infrastructure.
How much funding has Withings raised?
Withings has raised a total of $93.8M across 3 funding rounds:
Series A
$3.8M
Unspecified
$30M
Series B
$60M
Series A (2010): $3.8M with participation from Ventech Solutions
Unspecified (2013): $30M led by Bpifrance, 360 Capital Partners, Ventech Solutions, and Idinvest Partners
Series B (2020): $60M supported by ODDO BHF Private Equity, Adelie Capital, BNP Paribas Développement, Gilde Healthcare, Bpifrance, and Idinvest Partners
Key Investors in Withings
Gilde Healthcare
Gilde Healthcare is a specialized healthcare investment firm managing over 1.4 billion euros across three fund strategies, focusing on businesses that enable better care at lower costs.
Bpifrance
Founded in 2012, Bpifrance is a French public investment bank that supports companies at every stage of their development through credit, guarantees, and equity financing.
Idinvest Partners
Idinvest Partners is a mid-market private equity firm founded in 1997, dedicated to financing and supporting entrepreneurs throughout various stages of business development.
What's next for Withings?
With the successful closure of this major strategic investment, Withings is poised to enter a new phase of enterprise-level growth. The company is expected to prioritize the expansion of its B2B health services, focusing on remote patient monitoring and clinical-grade data solutions that integrate directly into healthcare provider workflows. By utilizing this capital, Withings will likely accelerate its R&D pipeline to introduce next-generation sensors and AI-driven health diagnostics. As the digital health market continues to mature, the firm's strategic focus will remain on maintaining its competitive edge through technological differentiation and deepening its partnerships with global healthcare institutions, ensuring that its hardware remains the gold standard for connected health monitoring.
See full Withings company page
